Donor regulatory T-cell therapy to prevent graft-versus-host disease
Key PointsTreg-engineered donor graft prevents acute and chronic GVHD.Patients treated with Treg-engineered graft who develop GVHD respond to primary corti
Related Articles
ANKRD26-related Thrombocytopenia 2 with a Baseline Increase in Blasts: Implications for Clinical Surveillance
We report eight patients with ANKRD26-related thrombocytopenia-2 (ANKRD26-RT) with elevated bone marrow myeloblasts and dysmegakaryopoiesis, without somati
ANKRD26-related Thrombocytopenia 2 with a Baseline Increase in Blasts: Implications for Clinical Surveillance
We report eight patients with ANKRD26-related thrombocytopenia-2 (ANKRD26-RT) with elevated bone marrow myeloblasts and dysmegakaryopoiesis, without somati
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia
Key PointsA stem cell–like cell of origin imparts high GATA2 expression in AML cells.GATA2 plays a direct role in modulating p53-induced apoptosis via the
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
Key Points. Revumenib exhibited a promising complete response rate and manageable safety profile in patients with NPM1-mutated relapsed/refractory AMLRespo
The JAK2 46/1 haplotype influences PD-L1 expression
Key PointsPD-L1 expression is increased in 46/1 haplotype carriers.3D chromatin structure differs between JAK2 haplotypes, and noncoding elements in the JA
Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study
Key PointsThe overall frequency of BTK mutations was low in zanubrutinib- and ibrutinib-treated patients experiencing early CLL progression in the ALPINE s
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease
Key PointsTemporal single-cell RNA sequencing of mouse blood identifies nonintuitive signatures of IL-17 and CSF-1 dysregulation during cGVHD.Analogous IL-
Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia
Key PointsIn this dose-finding phase 1 study, quercetin, a natural antioxidant was found to be safe and well tolerated in patients with FA.ROS levels decre
Myelodysplastic neoplasm with biallelic TP53 inactivation in a patient with plasma cell myeloma after cytotoxic therapy
Rong He, Dong Chen; Myelodysplastic neoplasm with biallelic TP53 inactivation in a patient with plasma cell myeloma after cytotoxic therapy. Blood 2025; 145 (19): 2230.…
Practical Solutions to Promoting Scholarly Output in Hematology Amid Cuts to Federally Funded Research | ASH Clinical News | American Society of Hematology
In this Letter to the Editor, Shyam A. Patel, MD, PhD, discusses the dependence academic institutions have on federal funding for research and where investigators…
